Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 28519-28520 [2014-11363]
Download as PDF
Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices
28519
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Expansion of WebPlus Tool to
Retrieve Cancer Registry Data for use in
Treatment Summaries for Cancer
Survivors, Special Interest Projects
(SIP)14–016; and Translating and
Communicating the Science of Breast
Cancer Prevention, SIP14–019, Panel J,
initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
The meeting announced below
concerns Integrating Self-Management
Training with Cancer Survivorship Care
Planning, Special Interest Projects
(SIP)14–015; Utilizing Data Linkages to
Populate Treatment Summaries for
Cancer Survivors, SIP14–017; and Skin
Cancer Prevention: Finding Messages
that Work to Reduce Incidental and
Intentional UV Exposure SIP14–018,
Panel B1, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
EMCDONALD on DSK67QTVN1PROD with NOTICES
Time and Date: 10:00 a.m.–5:00 p.m., June
5, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Expansion of WebPlus Tool to
Retrieve Cancer Registry Data for use in
Treatment Summaries for Cancer Survivors,
SIP14–016; and Translating and
Communicating the Science of Breast Cancer
Prevention, SIP14–019, Panel J, initial
review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 2014–11360 Filed 5–15–14; 8:45 am]
BILLING CODE 4163–18–P
Time and Date: 9:00 a.m.–6:00 p.m., June
3, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Integrating Self-Management
Training with Cancer Survivorship Care
Planning, SIP14–015; Utilizing Data Linkages
to Populate Treatment Summaries for Cancer
Survivors, SIP14–017; and Skin Cancer
Prevention: Finding Messages that Work to
Reduce Incidental and Intentional UV
Exposure SIP14–018, Panel B1, initial
review.’’
Contact Person for More Information:
Diana Bartlett, M.P.H., M.P.P., Health
Scientist, CDC, 1600 Clifton Road, NE.,
Mailstop D–72, Atlanta, Georgia 30333,
Telephone: (404) 639–4938,
ZXD5@CDC.GOV.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11354 Filed 5–15–14; 8:45 am]
BILLING CODE 4163–18–P
VerDate Mar<15>2010
20:00 May 15, 2014
Jkt 232001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
The meeting announced below
concerns Healthy Brain Initiative
Research Network (HBIN)—
Coordinating Center, Special Interest
Projects (SIP) 14–001, and Healthy Brain
Initiative Network, (HBIN)—
Collaborating Centers, SIP 14–002,
Panel F, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 9:30 a.m.–5:00 p.m., June
2, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Healthy Brain Initiative
Research Network (HBIN)—Coordinating
Center, SIP 14–001, and Healthy Brain
Initiative Network (HBIN)—Collaborating
Centers, SIP 14–002 Panel F, initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11353 Filed 5–15–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Workplace Health Research
E:\FR\FM\16MYN1.SGM
16MYN1
28520
Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices
Network (WHRN)—Coordinating Center,
Special Interest Projects (SIP)14–030;
Workplace Health Research Network
(WHRN)—Collaborating Centers, SIP14–
031; and Evaluation of Work-Related
Effects of the Chronic Disease SelfManagement Program (CDSMP), SIP14–
032, Panel K, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates: 9:30 a.m.–6:00 p.m., June
9, 2014 (Closed); 9:30 a.m.–6:00 p.m., June
10, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Workplace Health Research
Network (WHRN)—Coordinating Center,
SIP14–030; Workplace Health Research
Network (WHRN)—Collaborating Centers,
SIP14–031; and Evaluation of Work-Related
Effects of the Chronic Disease SelfManagement Program (CDSMP), SIP 14–032,
Panel K, initial review.’’
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D., M.S.E.H.,
F.A.C.E., Deputy Associate Director for
Science, National Center for Injury
Prevention and Control, CDC, 4770 Buford
Highway NE., Mailstop F–63, Atlanta,
Georgia 30341, Telephone: (770) 488–4655,
GXC8@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
EMCDONALD on DSK67QTVN1PROD with NOTICES
[FR Doc. 2014–11362 Filed 5–15–14; 8:45 am]
BILLING CODE 4163–18–P
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Physical Activity Policy and
Evaluation Research Network Plus
(PAPRN+): Coordinating Center, Special
Jkt 232001
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2014–11363 Filed 5–15–14; 8:45 am]
20:00 May 15, 2014
Times and Dates: 9:30 a.m.–6:00 p.m., June
11, 2014 (Closed). 9:30 a.m.–6:00 p.m., June
12, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Physical Activity Policy and
Evaluation Research Network Plus
(PAPRN+): Coordinating Center, (SIP)14–024,
and Physical Activity Policy Research
Network Plus (PAPRN+): Collaborating
Center, SIP14–025, Panel L, initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
VerDate Mar<15>2010
Interest Projects (SIP)14–024, and
Physical Activity Policy Research
Network Plus (PAPRN+): Collaborating
Center, SIP14–025, Panel L, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
The meeting announced below
concerns Research Grants for Preventing
Violence and Violence Related Injury,
Funding Opportunity Announcement
CE14–006, initial review.
SUMMARY: This document corrects a
notice that was published in the Federal
Register on April 29, 2014 (79 FR
23979). The time, date, and place
should read as follows:
Time and Date: 10:30 a.m.–5:30 p.m., June
5–6, 2014 (Closed).
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Place: CDC, 4770 Buford Highway NE.,
Conference Rooms 9A and 5A, Atlanta,
Georgia 30341.
FOR FURTHER INFORMATION CONTACT: Donald
Blackman, Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway NE., Mailstop
F63, Atlanta, Georgia 30341, Telephone:
(770) 488–0641, DBlackman@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–11356 Filed 5–15–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Facilitating the Evaluation of
the Processes and Impacts of the State
Driven Fall Prevention (SDFP) Project,
Special Interest Project (SIP)14–020,
Panel E1, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10:00 a.m.–5:00 p.m., June
5, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Facilitating the Evaluation of
the Processes and Impacts of the State Driven
Fall Prevention (SDFP) Project, SIP14–020,
Panel E1, initial review.’’
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D., M.S.E.H.,
F.A.C.E., Deputy Associate Director for
Science, National Center for Injury
Prevention and Control, CDC, 4770 Buford
Highway NE., Mailstop F–63, Atlanta,
Georgia 30341, Telephone: (770) 488–4655,
GXC8@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
E:\FR\FM\16MYN1.SGM
16MYN1
Agencies
[Federal Register Volume 79, Number 95 (Friday, May 16, 2014)]
[Notices]
[Pages 28519-28520]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11363]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Workplace Health Research
[[Page 28520]]
Network (WHRN)--Coordinating Center, Special Interest Projects (SIP)14-
030; Workplace Health Research Network (WHRN)--Collaborating Centers,
SIP14-031; and Evaluation of Work-Related Effects of the Chronic
Disease Self-Management Program (CDSMP), SIP14-032, Panel K, initial
review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Times and Dates: 9:30 a.m.-6:00 p.m., June 9, 2014 (Closed);
9:30 a.m.-6:00 p.m., June 10, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Workplace Health Research Network (WHRN)--Coordinating
Center, SIP14-030; Workplace Health Research Network (WHRN)--
Collaborating Centers, SIP14-031; and Evaluation of Work-Related
Effects of the Chronic Disease Self-Management Program (CDSMP), SIP
14-032, Panel K, initial review.''
Contact Person for More Information: Gwendolyn H. Cattledge,
Ph.D., M.S.E.H., F.A.C.E., Deputy Associate Director for Science,
National Center for Injury Prevention and Control, CDC, 4770 Buford
Highway NE., Mailstop F-63, Atlanta, Georgia 30341, Telephone: (770)
488-4655, GXC8@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention.
[FR Doc. 2014-11363 Filed 5-15-14; 8:45 am]
BILLING CODE 4163-18-P